malignant melanoma
DESCRIPTION
TRANSCRIPT
![Page 1: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/1.jpg)
Malignant Melanoma
By
Bill V. Way, DO
Dan Ladd Jr., DO
![Page 2: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/2.jpg)
A-B-C-D-E’s of Melanoma
• A - Asymmetry - several types
• B - Border Irregularity
• C - Colors - multiple
• D - Diameter - bigger than a pencil eraser
• E - Elevation, Erythema
![Page 3: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/3.jpg)
ASYMMETRY - WHAT DOES IT MEAN?
• One side differs from the other side
• Shape
• Color
• Elevation
• Borders
• Does the lesion mirror itself in every way?
• May be subtle.
![Page 4: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/4.jpg)
BORDERS
• May be “notched” or “jagged”
• May simply be blurred or indistinct.
• Can be indicative of the irregular growth of malignant melanocytes.
• Requires close inspection of lesion, preferably with a magnifying glass, may be subtle - take it seriously.
![Page 5: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/5.jpg)
COLOR
• Many benign lesions have 2 colors, tan and brown, but the color is symmetrically placed, ie., brown central with round peripheral tan ring.
• Look for multiple or asymmetrically positioned colors - may see red, white, tan brown or black.
• Again requires magnification, can be subtle.
![Page 6: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/6.jpg)
DIAMETER
• Always measure the greatest diameter.
• Include lighter or indistinct areas in your measurement, not just the darker pigment.
• Remember: PENCIL ERASER = 6 mm.
• Document size carefully if you are going to watch a lesion over time - consider the compliance level of your patient.
![Page 7: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/7.jpg)
ELEVATION
• Remember that if the lesion is melanoma, elevation above the surface means depth below, and is the single worst prognostic factor.
• Elevation need not be eccentrically located, the classic “fried egg” may appear fairly symmetric but requires biopsy.
• PALPATE !
![Page 8: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/8.jpg)
LET’S TRY A FEW…
![Page 9: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/9.jpg)
![Page 10: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/10.jpg)
Path: Junctional Nevus with Dysplastic Features,
![Page 11: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/11.jpg)
![Page 12: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/12.jpg)
Path: Compound Nevus with Features of “Dysplastic” (Clark)
Nevus
![Page 13: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/13.jpg)
![Page 14: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/14.jpg)
Path: Compound Nevus
![Page 15: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/15.jpg)
![Page 16: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/16.jpg)
Path: Pigmented Seborrheic Keratosis
![Page 17: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/17.jpg)
![Page 18: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/18.jpg)
Path: Compound Nevus
![Page 19: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/19.jpg)
![Page 20: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/20.jpg)
Path: Melanocytic Nevus, Compound Type
![Page 21: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/21.jpg)
![Page 22: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/22.jpg)
Path: Compound “Dysplastic” Melanocytic Nevus
![Page 23: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/23.jpg)
![Page 24: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/24.jpg)
Path: Compound “Dysplastic” Melanocytic Nevus
![Page 25: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/25.jpg)
![Page 26: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/26.jpg)
Path: Possible Early Evolving Melanoma In Situ
![Page 27: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/27.jpg)
![Page 28: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/28.jpg)
Path: Malignant Melanoma,Clarks Level IV,
Breslow’s Thickness 1.9 mm
![Page 29: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/29.jpg)
![Page 30: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/30.jpg)
Path: Melanoma In-Situ
![Page 31: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/31.jpg)
![Page 32: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/32.jpg)
Path: Evolving Melanoma In Situ
![Page 33: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/33.jpg)
![Page 34: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/34.jpg)
Path: Evolving Melanoma In-Situ
![Page 35: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/35.jpg)
![Page 36: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/36.jpg)
Path: Malignant Melanoma, Breslow’s Thickness 0.9 mm
![Page 37: Malignant Melanoma](https://reader036.vdocuments.net/reader036/viewer/2022081518/5485b1d0b4af9f33148b481d/html5/thumbnails/37.jpg)
THE END